The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature

Journal of NeuroVirology

Volumn 9, Issue SUPPL. 1, 2003, Pages 73-80

  Cinque, Paola ^a   Bossolasco, Simona ^a   Brambilla, Anna Maria ^a   Boschini, Antonio ^b   Mussini, Cristina ^c   Pierotti, Chiara ^a   Campi, Adriana ^a   Casari, Salvatore ^d   Bertelli, Davide ^e   Mena, Maurizio ^f   Lazzarin, Adriano ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b San Patrignano Medical Center   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e SPEDALI CIVILI   (Italy)

^f ASST Ovest Milanese   (Italy)

Author keywords

HAART; Immune reconstitution; PML

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; REVIEW; SYMPTOMATOLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0038475695     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390195351     Document Type: Review

References (20)

1. Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A (2001). Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J NeuroVirol 7: 323-328.
2. Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998). Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341-349.
3. Cinque P, Pierotti C, Vigano MG, Bestetti A, Fausti C, Bertelli D, Lazzarin A (2001). The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J NeuroVirol 7: 358-363.
4. Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fornara C, Racca S, Castagna A, D'Arminio Monforte A, Wahren B, Lazzarin A, Linde A (1996). Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951-958.
5. Collazos J, Mayo J, Martinez E, Blanco MS (1999). Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 13: 1426-1428.
6. Cooney EL (2002). Clinical indicators of immune restoration following highly active antiretroviral therapy. Clin Infect Dis 34: 224-233.
7. De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, Monforte A, Antinori A (2001). Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. J NeuroVirol 7: 364-368.
8. DeSimone JA, Pomerantz RJ, Babinchak TJ (2000). Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133: 447-454.
9. Garcia De Viedma D, Diaz Infantes M, Miralles P, Berenguer J, Marin M, Munoz L, Bouza E (2002). JC virus load in multifocal progressive leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival and the volume of neurological lesions. Clin Infect Dis 34: 1568-1575.
10. Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30:95-99.
11. Koralnik IJ, Du Pasquier RA, Kuroda MJ, Schmitz JE, Dang X, Zheng Y, Lifton M, Letvin NL (2002). Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 168: 499-504.
12. Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS (1998). Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? Am J Med 105: 541-543.
13. Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, QueenBaker J, Andersen J, Kelly S, Shriver S (2002). A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16:1791-1797.
14. Mayo J, Collazos J, Martinez E (1998). Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy. AIDS 12: 1722
15. Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, Munoz L, Garcia-de-Viedma D (2001). Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15: 1900-1902.
16. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW (2002). Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81: 213-227.
17. Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1999). Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28: 1152-1154.
18. Thurnher MM, Post MJ, Rieger A, Kleibl-Popov C, Loewe C, Schindler E (2001). Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol 22: 977-984.
19. Woo HH, Rezai AR, Khopp EA, Weiner HL, Miller DC, Kelly PJ (1996). Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report. Neurosurgery 39: 1031-1034; discussion, 1034-1035.
20. Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gravell M, Hou J, Clifford DB, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 45: 816-821.